Ribbon Biolabs successfully synthesises a 10 kbp DNA molecule using their FullGenes platform 21 May 2021, Vienna, Austria: The DNA Synthesis company Ribbon Biolabs announces the achievement of a key technology milestone, underlining its capability and potential. Using...

For the first time ever, SynBioBeta is hosting a special, one-day special on all hot topics in biopharma. We are looking forward to meeting you there! https://synbiobetaevents.com/biopharma-conference-2021

Prof. Eörs Szathmary of Eötvös University in Hungary  has been elected to the Humanities and Social Sciences section of the Norwegian Academy of Sciences and Letters. As a member of Ribbon Biolabs’ Advisory Board, he has been supporting the companies development since...

Meet us on September 23 and the Life Science Career Fair! The Annual ÖGMBT Meeting is the melting pot of the Austrian Life Science Community – this year it is held virtually and will kick-off a 6 month VirtualExpo and Life Science Career Fair, the place to be for...

Ribbon Biolabs’ CEO is discussing the funds required to develop a coronavirus vaccine in an online special event organized by the online magazine Metropole: https://metropole.at/funding-a-new-future-the-race-for-a-vaccine/

We are honored to be featured on LABIOTECH.eu as ‘Startup of the Week’. Thanks to Jonathan Smith for the comprehensive article! https://www.labiotech.eu/biotech-of-the-week/ribbon-biolabs-synthetic-biology/

The Austrian Innovation and Start-up-Portal reports about Ribbon Biolabs’ recent investment round: https://www.trendingtopics.at/biotech-startup-ribbon-biolabs-bekommt-finanzspritze/